tiprankstipranks
Advertisement

VFVA - ETF AI Analysis

Compare

Top Page

VFVA

Vanguard U.S. Value Factor ETF (VFVA)

Rating:69Neutral
Price Target:
VFVA, the Vanguard U.S. Value Factor ETF, is rated as a solid, quality fund, largely because many of its biggest holdings like Verizon and Salesforce combine strong financial performance with clear growth strategies and supportive earnings call commentary. These strengths are partly offset by holdings such as CVS Health and General Motors, where profitability, leverage, and valuation concerns introduce more uncertainty. A key risk factor is the fund’s exposure to companies facing sector-specific pressures and high debt or overvaluation, which could add volatility even within this value-focused strategy.
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year and in recent months, showing solid momentum.
Broad Sector Diversification
Holdings spread across financials, health care, consumer sectors, technology, energy, and more help reduce the impact of weakness in any single industry.
Low Expense Ratio
The fund’s relatively low ongoing fee means more of the ETF’s returns stay in investors’ pockets over time.
Negative Factors
Heavy U.S. Concentration
With almost all assets in U.S. companies, the fund offers limited diversification across global markets.
Mixed Top-Holding Performance
Some of the largest positions have shown weak or negative performance this year, which could drag on overall returns if the trend continues.
Significant Financial Sector Exposure
A large allocation to financial stocks means the ETF may be more sensitive to interest rate changes and stress in the banking sector.

VFVA vs. SPDR S&P 500 ETF (SPY)

VFVA Summary

Vanguard U.S. Value Factor ETF (VFVA) is a U.S.-focused fund that follows a “value” theme, aiming to invest in companies that appear cheap compared with their business fundamentals. It spreads your money across many sectors, including financials, health care, and technology. Well-known holdings include Salesforce and General Motors. Someone might invest in VFVA to tilt their portfolio toward value stocks, which can add diversification and potential long-term growth compared with broad market funds. A key risk is that value stocks can stay out of favor for long periods, so the ETF’s price can go up and down more than you expect.
How much will it cost me?The Vanguard U.S. Value Factor ETF (VFVA) has an expense ratio of 0.13%, meaning you’ll pay $1.30 per year for every $1,000 invested. This is lower than average because it is passively managed, focusing on a value-oriented strategy that keeps costs down while providing diversified exposure to undervalued stocks.
What would affect this ETF?The Vanguard U.S. Value Factor ETF (VFVA) could benefit from a strong U.S. economy, particularly if undervalued sectors like Financials, Health Care, and Consumer Cyclical experience growth. However, rising interest rates or economic slowdowns could negatively impact some of its top holdings, such as banks and consumer-focused companies, while regulatory changes in sectors like Health Care or Technology may also pose risks.

VFVA Top 10 Holdings

VFVA leans into classic U.S. value names, with financials and health care doing much of the heavy lifting. US Bancorp and Bristol-Myers Squibb have been steadily rising, giving the fund a solid backbone, while energy player EOG Resources adds extra punch with strong recent gains. On the flip side, tech exposure is a bit of a double-edged sword: Intuit and Salesforce have been losing steam, tempering overall returns. With all holdings U.S.-based and spread across banks, drugmakers, telecom, and energy, the fund is value-focused but not overly tied to any single stock.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Bristol-Myers Squibb0.87%$7.98M$133.41B47.66%
78
Outperform
EOG Resources0.87%$7.97M$79.20B27.52%
78
Outperform
Salesforce0.83%$7.54M$150.71B-26.61%
80
Outperform
General Motors0.82%$7.47M$77.97B69.16%
73
Outperform
Intuit0.80%$7.27M$86.46B-59.28%
73
Outperform
Cigna0.78%$7.09M$73.74B6.41%
72
Outperform
Verizon0.74%$6.76M$195.46B9.16%
81
Outperform
AT&T0.74%$6.73M$159.32B-16.22%
71
Outperform
CVS Health0.73%$6.68M$133.25B67.17%
64
Neutral
US Bancorp0.71%$6.45M$98.17B43.40%
76
Outperform

VFVA Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
149.14
Positive
100DMA
143.64
Positive
200DMA
137.98
Positive
Market Momentum
MACD
RSI
STOCH
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VFVA, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 153.82, equal to the 50-day MA of 149.14, and equal to the 200-day MA of 137.98, indicating a bullish trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VFVA.

VFVA Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$913.13M0.13%
69
Neutral
$643.83M0.40%
74
Outperform
$591.24M0.28%
73
Outperform
$425.90M0.38%
71
Outperform
$311.36M0.60%
70
Outperform
$248.93M0.50%
70
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
VFVA
Vanguard U.S. Value Factor ETF
157.06
41.46
35.87%
LSVD
LSV Disciplined Value ETF
QVAL
Alpha Architect U.S. Quantitative Value ETF
AIVL
WisdomTree U.S. AI Enhanced Value Fund
BUSA
Brandes U.S. Value ETF
GVLU
Gotham 1000 Value ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement